0001209191-21-002422.txt : 20210106 0001209191-21-002422.hdr.sgml : 20210106 20210106211514 ACCESSION NUMBER: 0001209191-21-002422 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosen Karin CENTRAL INDEX KEY: 0001831048 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 21512750 MAIL ADDRESS: STREET 1: C/O HORIZON THERAPEUTICS, INC. STREET 2: CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD CITY: DUBLIN STATE: L2 ZIP: D04 C5Y6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-04 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001831048 Rosen Karin C/O HORIZON THERAPEUTICS, INC. CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 D04 C5Y6 IRELAND 0 1 0 0 EVP, R&D & CSO Restricted Stock Units (RSU) 2021-01-04 4 A 0 24449 0.00 A Ordinary Shares 24449 24449 D Each RSU represents a contingent right to receive one ordinary share of the Issuer. The RSU's vest 1/3rd annually on each anniversary of January 5, 2020. /s/ Miles W. McHugh, Attorney-in-Fact 2021-01-06